These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34839416)

  • 1. Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study.
    Yang S; Chai D; Li Y; Wang Y; Zhan X; Zhang L; Wang J; Ye Q
    Clin Rheumatol; 2022 Mar; 41(3):783-793. PubMed ID: 34839416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study.
    Watanabe T; Minezawa T; Hasegawa M; Goto Y; Okamura T; Sakakibara Y; Niwa Y; Kato A; Hayashi M; Isogai S; Kondo M; Yamamoto N; Hashimoto N; Imaizumi K
    BMC Pulm Med; 2019 Nov; 19(1):194. PubMed ID: 31675941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factor.
    Maillet T; Goletto T; Beltramo G; Dupuy H; Jouneau S; Borie R; Crestani B; Cottin V; Blockmans D; Lazaro E; Naccache JM; Pugnet G; Nunes H; de Menthon M; Devilliers H; Bonniaud P; Puéchal X; Mouthon L; Bonnotte B; Guillevin L; Terrier B; Samson M;
    J Autoimmun; 2020 Jan; 106():102338. PubMed ID: 31570253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of protein A immunoadsorption and therapeutic plasma exchange in ANCA-associated vasculitis with severe renal involvement: a retrospective study.
    Liu X; Xia M; Liu D; Liu H; Tang C; Chen G; Liu Y; Yuan F; Liu H
    Ann Med; 2023 Dec; 55(1):2230875. PubMed ID: 37452682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single-Centre Observational Study.
    Ha JW; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
    J Immunol Res; 2022; 2022():2499404. PubMed ID: 35655922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical differences among patients with myeloperoxidase-antineutrophil cytoplasmic antibody-positive interstitial lung disease.
    Yamaguchi K; Yamaguchi A; Ito M; Wakamatsu I; Itai M; Muto S; Uno S; Aikawa M; Kouno S; Takemura M; Yatomi M; Aoki-Saito H; Koga Y; Hara K; Motegi S; Tsukida M; Ota F; Tsukada Y; Motegi M; Nakasatomi M; Sakairi T; Ikeuchi H; Kaneko Y; Hiromura K; Maeno T
    Clin Rheumatol; 2023 Feb; 42(2):479-488. PubMed ID: 36194347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients.
    Hu X; Shen C; Meng T; Ooi JD; Eggenhuizen PJ; Zhou YO; Luo H; Chen JB; Lin W; Gong Y; Xiong Q; Xu J; Liu N; Xiao X; Tang R; Zhong Y
    Front Immunol; 2022; 13():991469. PubMed ID: 36389826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Interstitial Lung Disease and Prognosis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Zhou P; Li Z; Gao L; Zhao B; Que C; Li H; Ma J; Wang G
    Respiration; 2023; 102(4):257-273. PubMed ID: 36693330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary involvement in antineutrophil cytoplasmic antibody-associated vasculitides: A single center experience from Turkey.
    Yildirim Dogan HG; Yildirim F; Icacan OC; Yalcin Mutlu M; Celik S; Bes C
    Int J Rheum Dis; 2023 Aug; 26(8):1495-1503. PubMed ID: 37287386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients: Comparison With Idiopathic Pulmonary Fibrosis.
    Kwon M; Lee AS; Mira-Avendano I; Rojas CA; Grage R; Abril A
    J Clin Rheumatol; 2021 Dec; 27(8):324-330. PubMed ID: 32251058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis.
    Yen CL; Tian YC; Wu HH; Tu KH; Liu SH; Lee CC; Fang JT; Yang CW; Li YJ
    J Formos Med Assoc; 2019 Oct; 118(10):1408-1415. PubMed ID: 31133523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody-associated Vasculitis-related Bronchiectasis: Data from 61 Patients.
    Lhote R; Chilles M; Groh M; Puéchal X; Guilpain P; Ackermann F; Amoura Z; Annesi-Maesano I; Barba T; Catherinot E; Cohen-Aubart F; Cohen P; Cottin V; Couderc LJ; De Boysson H; Delbrel X; Dominique S; Duhaut P; Fain O; Hachulla E; Hamidou M; Kahn JE; Legendre C; Le Quellec A; Lhote F; Lifermann F; Mathian A; Néel A; Nunes H; Subra JF; Terrier B; Mouthon L; Diot E; Guillevin L; Brillet PY; Tcherakian C;
    J Rheumatol; 2020 Oct; 47(10):1522-1531. PubMed ID: 31787599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features and mortality.
    Doliner B; Rodriguez K; Montesi SB; Fu X; Sharma A; Wallace ZS
    Rheumatology (Oxford); 2023 Feb; 62(2):716-725. PubMed ID: 35699465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis: The Influence of ANCA Subtype.
    Mohammad AJ; Mortensen KH; Babar J; Smith R; Jones RB; Nakagomi D; Sivasothy P; Jayne DRW
    J Rheumatol; 2017 Oct; 44(10):1458-1467. PubMed ID: 28765242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiologic and pathologic characteristics of myeloperoxidase-antineutrophil cytoplasmic antibody-associated interstitial lung disease: a retrospective analysis.
    Baqir M; Yi EE; Colby TV; Cox CW; Ryu JH; Specks U
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):195-201. PubMed ID: 32476954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary involvement in ANCA-associated vasculitis from the view of the pulmonologist.
    Homma S; Suzuki A; Sato K
    Clin Exp Nephrol; 2013 Oct; 17(5):667-671. PubMed ID: 23188194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patients.
    Tanaka T; Otani K; Egashira R; Kashima Y; Taniguchi H; Kondoh Y; Kataoka K; Shiraki A; Kitasato Y; Leslie KO; Fukuoka J
    Respir Med; 2012 Dec; 106(12):1765-70. PubMed ID: 22992339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.